Thursday, 21 June 2018

Campus Ambassadors (Students) required all across India_At Pharmacy institute level

Pharma Literati is pleased to announce the campus ambassador opportunities for undergraduate/ post-graduate students in pharmacy/ life sciences domain. 

Looking for passionate, career-focused, highly motivated individuals who wish to join the dynamic team of Pharma Literati as campus ambassador

What would you do as campus ambassador?
1.     You would be a single point contact for pharma literati team for the institute.
2.     You need to provide information related to events at your college to our forum. This would get published via the blog.
3.    Also, you need to distribute the newsletters by Pharma Literati at the institute level.
4.  You also need to provide information related to various initiatives taken by Pharma Literati team and the Centre of Excellence for Pharma Education at your institute.
5.  You would receive a certificate as a campus ambassador from the Pharma Literati Centre of Excellence. 
6. You would be eligible to participate in our various initiatives free of cost. 
7. You would be part of WhatsApp group comprising various campus Ambassadors, which would be a knowledge sharing platform for the students. 
8. You need to write articles, interviews, news item etc.
9. Top 3 campus Ambassadors would be get an internship opportunity with stipend of 10000 Rs, 7500 Rs and 5000 Rs during April to June 2019.

For any queries, please send an email to pharmaliterati@gmail.com

Send your CVs to pharmaliterati@gmail.com before 31st July, 2018. One or two candidates to be shortlisted per institute.

Tuesday, 5 June 2018

Sunday, 3 June 2018

CPIPR Enters 3rd Batch - July to October 2018

Pharma Literati Centre of Excellence in Pharma Education announces the 3rd Batch of CPIPR (Certificate Course in Pharmaceutical Intellectual Property Rights). More than 150 students have already taken this course in the first 2 batches. 


For whom?
1.             Pharmacy/ Chemistry/ Biosciences/ Life sciences/ Biotechnology/ Zoology/ Botany students in undergraduate/ post graduate / PhD/ Research fellows;
2.             Faculties form any of these streams;
3.             Industry professionals** from Pharma/ Biotechnology/ Life sciences;
4.             Anyone who is willing to make a career in R & D; Business development; International Business; Drug discovery; Generic drug development; Academic research; Regulatory affairs; Intellectual Property Rights and the like;
5.             Students willing to pursue higher studies in USA/Europe/ Canada/ Australia/ Russia/ Korea/ Japan/ other countries as PhD/ MBA/ MS/ Masters.
** Since this is a basic level course, it is designed for non-IPR professionals.

Significance of the course:
Life sciences is going through a transition phase with abundant activities in Research and Development arena. The increased focus to R & D in academia and industries has led to Intellectual Property Rights at the centerstage. The increase in patenting activities by the academia is a welcome sign for bridging the industry academia gap.

We at Pharma Literati are proud to be associated with many institutes in these activities and are on a mission called “Pharma Innovation Yatra, 2017”. As a part of these activities, we are proud to announce another effort to fill the vacuum which was observed in many institutes during this yatra by launching this course on IPR.

The upgraded syllabus of pharmacy at many institutes, universities includes IPR as a core subject or a part of the subject. However, the thorough understanding of the subject is needed considering its global nature. We believe the course would be a stepping stone in this long journey of Innovation.
  
USP of CPIPR?
1.    Specially designed basic level course for Patents and IPR;
2.    Customized for the pharmaceutical industry;
3.    Delivered by the faculty from the industry;
4.  This is an effort of bridging the industry - academia gap highlighting the significance of Intellectual Property Rights to the pharmacy professionals and students;

Course contents:
This course consists 6 different modules:
Module
Title
Details
I
The pharmaceutical business
The module discusses the working of the pharmaceutical industry and the business models globally.
II
The pharmaceutical R & D
This module discusses the working of the R & D teams.
III
Intellectual Property Rights: Introduction
This module discusses various forms of Intellectual Property Rights.
IV
IPR: With specific reference to pharma
This module discusses the patentability criteria with specific reference to pharmaceutical industry including various related terminologies.
V
IPR: Indian patent scenario
This module discussed the Indian patent scenario.
VI
Patent commercialization and licensing
This module discusses the basics of patent licensing and commercialization of the invention.

Course duration:
3 months including the online lectures.
  
Course methodology:
·      The course consists of 6 different modules. The course contents would be available online in the PDF format.
·       Fortnightly, one module would be uploaded on the website and would be available to study. The students can also download the contents for the future reference.
·       For each module, there would be one session by course faculty.
·     The students have an option to be part of the WhatsApp group for discussion and solving the queries for the course.
·      At the end of the course, an online examination would be conducted. The examination would be based on the contents of the modules and the news items on the Pharma Literati blog. The questions would be multiple choice questions. Students need to subscribe or visit to the blog free of cost.
·       The successful students would receive the certificate at their address of correspondence.

Benefits of the course:
·     Certificate would be provided to the students completing the course successfully.
·     Alumni status of Pharma Literati’s centre of excellence in pharma education, providing free access to the events and all the competitions.
·       Interaction with the industry experts and their live experiences.
·       Assistance in patent filing for the inventions at the institutes.
·       Access to the events and programs of the partner institutes.
·       Discounts upto 35 % for the other courses of the centre of excellence.
·       Access to whatsapp group as member.

Course fees:
Fees for the students:     Rs. 6000 + 1080 (GST) = 7080 Rs.
For others:                       Rs. 8000 + 1440 (GST) = 9440 Rs.
Send an email to pharmaliterati@gmail.com to know the mode of payment.


Please fill the forms at: 






Saturday, 2 June 2018

India’s e-health initiatives

India’s e-health initiatives
India’s e-health initiatives
Health and Family Welfare Minister JP Nadda has said the resolution on digital health brought out by India was adopted by the 71st World Health Assembly, the decision-making body of the World Health Organization (WHO). Nadda stressed on the importance of building digital health ecosystem partnerships with private healthcare providers, academia, health IT practitioners, industry, patient groups and regulatory bodies. He had also said India was planning to create an integrated digital health platform and enable creation of electronic health records for the 1.3 billion people of India.  

e-Healthcare would cover online medical consultation, online medical records, online medicine supply, pan-India exchange for patient information, etc. National Health Portal (NHP) provides information to citizens and stakeholders in different languages (currently six languages Hindi, English, Tamil, Gujarati, Bengali, and Punjabi). A voice portal, providing information through a toll-free number 1800-180-1104 and Mobile App are also available. Online Registration System (ORS) launched in July 2015 provides services to citizens for taking online registration & appointment, payment of fees, online viewing diagnostic reports, enquiring availability of blood online etc. in various public hospitals. As on date, over 100 hospitals are on boards.



To empower citizens to participate in improvement of healthcare service delivery by providing feedback on service quality, facilities etc. at hospitals and ultimately help establish patient driven, responsive and accountable healthcare system, `Mera Aspataal’ (Patient Feedback) application has been launched. 'Sugam' application provides a single window for multiple stakeholders (Pharma Industry, Regulators, Citizens) involved in the processes of Central Drugs Standards Control Organisation. Food Safety and Standards Authority of India is offering services for Online License, Clearance, Product approval to the Food Business Operators.  

In order to promote organ donation amongst citizens at large, National Organ & Tissue Transplant Organisation through its web-portal offers services for Online Registration for Organ/Tissue Transplantation or Retrieval and Online pledge registry by citizen for organ donation. Currently, over 12 crore pregnant women and around 11 crore children have been registered on MCTS / RCH portal since inception. mDiabetes is a mobile-based initiative for prevention and care of diabetes by giving a missed call to 011-22901701. ANM on Line (ANMOL).  A tablet-based application for Integrated RCH Register which allows ANMs to enter and update data.

Source:http://www.thehansindia.com/posts/index/Hans-Classroom/2018-05-30/Indias-e-health-initiatives/385197



Chemists synthesize and screen massive library of nonnatural proteins. Such screens could yield protein drugs with advantages over natural ones




09622-scicon2-structure.jpg
Chemists varied a nine-amino-acid string (green) in EETI-II. The protein's β-sheets are shown as flat, gray areas, and its disulfide bonds are indicated in yellow. Credit: Proc. Natl. Acad. Sci. USA

Researchers have synthesized and screened a library of small proteins composed entirely of nonnatural amino acids. In these 29-amino-acid miniproteins, called xenoproteins because of their “foreign” content, all the natural l-amino acids were replaced with mirror-image d-amino acids.
Such libraries could yield novel therapeutic agents with key advantages over natural protein-based drugs. Nonnatural miniproteins have enhanced temperature stability, making it easier to store and transport them without refrigeration, and the biomolecules resist enzymatic breakdown in the body.
Bradley L. Pentelute and coworkers at Massachusetts Institute of Technology used combinatorial solid-phase synthesis to create a library of 200 million xenoproteins based on EETI-II, a 29-residue protein with three disulfide links that fold it into a knot. In a string of nine residues in a protein loop, the team varied the amino acids randomly from a group of 16 d-amino acids (Proc. Natl. Acad. Sci. USA 2018, DOI: 10.1073/pnas.1722633115).
Most previous nonnatural peptide libraries had fewer members, consisted of smaller molecules, and varied fewer positions, the researchers say. Pentelute and coworkers evaluated one-tenth of the massive library and isolated specific xenoproteins that bound to an antibody by using both magnetic and fluorescent screening methods. They then used a combination of liquid chromatography and tandem mass spectrometry to identify sequences of the most potent binders.
The group is currently collaborating with the U.S. Army Medical Research Institute of Infectious Diseases to use a xenoprotein library to identify modified miniproteins that bind an Ebola virus glycoprotein.
Source:https://cen.acs.org/pharmaceuticals/drug-discovery/Chemists-synthesize-screen-massive-library/96/i22

Friday, 1 June 2018

Growth of Phamaceutical Industry in India.


Growth


  • The Indian pharmaceuticals market witnessed growth at a CAGR of 5.64 per cent, during FY11-16, with the market increasing from US$ 20.95 billion in FY11 to US$ 27.57 billion in FY16. The industry’s revenues are estimated to have grown by 7.4 per cent in FY17.
  • Indian pharmaceutical market grew 5.5 per cent in CY2017 in terms of moving annual turnover. In March 2018, the market grew at 9.5 per cent year-on-year with sales of Rs 10,029 crore (US$ 1.56 billion).
  • By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and 6th largest market globally in absolute size.
  • Increase in the size of middle class households coupled with the improvement in medical infrastructure and increase in the penetration of health insurance in the country will also influence in the growth of pharmaceuticals sector.
Growth
  • Indian pharma companies are capitalising on export opportunities in regulated and semi-regulated markets
  • In FY17, India exported pharmaceutical products worth US$ 16.8 billion, with the number expected to reach US$ 40 billion by 2020. During April 2017–February 2018, India exported pharmaceutical products worth Rs. 767.17 billion (US$ 11.90 billion).
  • Indian drugs are exported to more than 200 countries in the world, with the US as the key market
  • India is the world’s largest provider of generic medicines; the country’s generic drugs account for 20 per cent of global generic drug exports (in terms of volumes)
  • Around 40.6 per cent of India’s US$ 16.8 billion pharmaceutical exports in 2016-17 were to the American continent, followed by a 19.7 per cent to Europe, 19.1 per cent to Africa and 18.8 per cent to Asian countries.

Introduction

India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume. Of late, consolidation has become an important characteristic of the Indian pharmaceutical market as the industry is highly fragmented.
India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.
The UN-backed Medicines Patent Pool has signed six sub-licences with Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs, allowing them to make generic anti-AIDS medicine TenofovirAlafenamide (TAF) for 112 developing countries.

Market Size

Indian pharmaceutical sector is estimated to account for 3.1 – 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. It is expected to grow to US$100 billion by 2025. The market is expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest pharmaceutical market globally by absolute size. Branded generics dominate the pharmaceuticals market, constituting nearly 80 per cent of the market share (in terms of revenues). The sector is expected to generate 58,000 additional job opportunities by the year 2025. *
India’s pharmaceutical exports stood at US$ 16.8 billion in 2016-17 and are expected to grow by 30 per cent over the next three years to reach US$ 20 billion by 2020, according to the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL). Export of pharmaceutical items reached Rs. 696.84 billion (US$ 10.76 billion) during April 2017 – January 2018.
Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.
India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion).

Investments

The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.
The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 15.59 billion between April 2000 and December 2017, according to data released by the Department of Industrial Policy and Promotion (DIPP).
Some of the recent developments/investments in the Indian pharmaceutical sector are as follows:
  • As of March 2018, a consortium led by Indian private equity firm Chrys Capital is planning to buy a 10 per cent stake in Mankind Pharma for US$ 350 million.
  • The exports of Indian pharmaceutical industry to the US will get a boost, as branded drugs worth US$ 55 billion will become off-patent during 2017-2019.#
  • Private equity and venture capital (PE-VC) investments in the pharmaceutical sector have grown at 38 per cent year-on-year between January-June 2017, due to major deals in this sector.

Government Initiatives

Some of the initiatives taken by the government to promote the pharmaceutical sector in India are as follows:
  • In March 2018, the Drug Controller General of India (DCGI) announced its plans to start a single-window facility to provide consents, approvals and other information. The move is aimed at giving a push to the Make in India initiative.
  • The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy, in order to stop any misuse due to easy availability.
  • The Government of India unveiled 'Pharma Vision 2020' aimed at making India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investments.
  • The government introduced mechanisms such as the Drug Price Control Order and the National Pharmaceutical Pricing Authority to deal with the issue of affordability and availability of medicines.

Road Ahead

The Indian pharmaceutical market size is expected to grow to US$ 100 billion by 2025, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others. Pharma sector’s revenues are expected to grow by 9 per cent year-on-year through fiscal 2020.
Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.
The Indian government has taken many steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies.
Source: https://www.ibef.org/industry/pharmaceutical-india.aspx

Career Paths after Graduation in Pharmacy (Pharmaceutical Sciences)

Here’s an introduction to the various career paths in the Pharma industry.
Research & Development
If you are really enjoying the core subjects like Medicinal Chemistry, Pharmaceutics, Pharmacology during your 3rd and 4th year of B.Pharma, then you could consider a career in research and development. You can get R&D roles within pharmaceutical, biotech, agro and FMCG sectors.
Ideally you will need to have M.Pharma, MS or PhD degree. GPAT qualified candidates do get preferences. If you wish to purse M.Pharma from some of the top institutes like NIPER, then do start your preparation from the 3rd year itself.
Other options will be going for MS (or MSc) abroad. The B.Pharma course itself does not provide that much research opportunities. So, a foreign education and training will really help you. With B.Pharma background you can specialize in Pharmacology, Drug Delivery, Drug Chemistry, Biochemistry etc.
In India, an M.Pharm graduate can start with 22K per month (average), and the salary package can be 42K per month (average) after 5 years if you do not add any further skills or qualifications to your name.

Analytical R&D and Formulation Development (F&D)

Few people might consider QC / QA roles as boring. But, if you are skilled and intelligent, you can make a satisfying and rewarding career. Assay development and assay validation roles are really exciting. M.Pharma with Pharmaceutical Chemistry or Pharmaceutical Biotechnology specialization will help you in this role, also known as Analytical R&D.
Here are the top Analytical R&D profiles (according to LinkedIn). Similarly, formulation development (F&D) is also an exciting function for M.Pharma graduates with Pharmaceutics or Pharmaceutical Chemistry specializations.
Identifying new and more effective formulations (combinations of active drugs and other constituents) is as important as finding a new drug molecule.
A fresher in India will earn something between 8K – 18K per month. Yes, the starting salary could be quite low; but after 5 years you can see yourself taking home 32K – 42K per every month, provided you keep on learning new techniques and methods.

Manufacturing, Quality Control, Quality Assurance, Regulatory Affairs

If you are not too keen about research and development but you want to stay in the core domain – go for roles within QC & QA. With a PG Diploma (or Masters) in Pharmaceutical Regulatory Affairs or Pharmacovigilance and with few years of experience in the industry can really help you in terms of career progression and financial growth. Another less explored job function is medical writing.
If you have got sound knowledge about Pharmaceutical Sciences, like being creative, have got a flair for writing, possess attention-to-details, and happy with desk job – then do try Medical Writing.
The number of medical writing jobs in India is on the rise; and the pay packages are also good. Manufacturing (or production) also involves QC/QA because each and every batch need to maintain a certain level of efficacy and safety. The pay packages are similar to the above job roles (Analytical R&D and F&D).

Sales & Marketing

The sales and marketing job function absorbs the maximum number of pharmacy graduates. My class of B.Pharm (batch of 2004 – 2008) consisted of 90 students. Approximately 40 – 50 students started in the sales domain (as Medical Representative aka MR) after graduation.
The number of jobs available in the sales function is plenty. The salary structure is also decent. More importantly, on good performance the incentives are really lucrative. The job is challenging of course, but rewarding as well.
You have to travel a lot, and you do get chances to travel to new places in India and abroad (sponsored by employers). The pressure of achieving targets is obviously there, but the targets are quite achievable most of the time, at least according to my batch mates, juniors and seniors.
If you are dynamic, pro-active, confident (go-getter attitude) and like talking, negotiating, travelling and making money – this role is definitely for you.
Few people think that Medical Representative is just any sales job – WRONG. You have to advise the Medical Doctors about the pharmacological effects of the drug, their optimum doses, indications for specific diseases, side-effects and contraindications. So, your subject knowledge and communication skills need to be on par.
You always need to be updated with the current market knowledge, scientific research and many other things. People might also think that even B.Sc. graduates can also do MR jobs – true.
But, if you are from B.Pharm background, then you will have various advantage during your job duties. You can get promoted from Field Officer to Area Manager level within 3 years (on average it takes 2 to 5 years). You can also move in to the Product Management Team (PMT) with 4 – 7 years of experience under your belt.
M.Pharm candidates with Pharmacology specialization or MBA graduates can also get PMT jobs. You will be dealing with making strategy, sales, marketing, analysis and financial stuff a lot within the PMT.
If you land up as a Medical Representative after B.Pharm, you can expect to earn something between 14,000 and 25,000 Rupees per month (excluding incentives). With experience and promotions, you can end up earning between 25K and 32K per month, after 3 years. If you switch to PMT or do an MBA after 3 years, you can land up with 40K to 60K per month (again excluding incentives). So monetarily, this is the most rewarding job role.

Academia

M.Pharm graduates are the ideal candidates to get Lecturer roles. But, Pharm.D candidates are also eligible for lecturer jobs. Clearing GPAT, NET, SLET will be of great advantage. Almost every state in India has got decent number of Pharmacy colleges. Andhra Pradesh, Karnataka, Gujarat, Haryana, Madhya Pradesh, Maharashtra, Tamil Nadu, Punjab, Rajasthan, Uttar Pradesh, Kerala have got the Pharmacy Colleges in the range of 60 – 200.
B.Pharm graduates can also get Lecturer jobs in D.Pharm colleges. In the academia you will also have the opportunity to be involved in research as well, though not all the colleges will have the quality research scope.
You can also undertake part-time PhD while teaching undergraduate and post-graduate students. An extensive lists of Pharmacy Colleges in India, segregated state-wise, can be found here as well.
The starting salary can be as low 8K – 18K per month with M.Pharm qualification, but the job could be quite relaxing with lot of benefits like housing and/or numerous holidays. After 5 years, if you do not go for a PhD (full-time or part-time), you can still earn around 30K per month. For quality life-work balance, this could be a nice role.

Hospital / Clinical / Community Pharmacy

Community Pharmacy is one of the core career opportunities, and will be most suited to PharmD graduates. The role involves counselling patients, advising them on dosage and intake for taking the medicines. This is a very critical role and demands considerable knowledge and skills.
However, in India the concept is very much unknown due to several reasons. The Government, PCI and other authorities (like Indian Pharmaceutical Association) are taking steps. However, it will take time.
The vacancies for Pharmacist in Hospitals, Railways, Armed Forces are there, but they are too few to accommodate even 10% (the figure could be even less than that) of Pharmacy graduates that pass out annually.

Other Career Paths for Pharm.D graduates (and those who want to stay in Core Community Pharmacy Domain)

  • Higher Studies Abroad: You can go for Masters in Public Health or Masters in Health Management in countries where the community pharmacy is in huge demand (USA, Canada, Australia, UK etc.). In the US, the number of shortage of healthcare professionals is supposed to be 250,000 by 2020. So, US will definitely be a country to look up to.
    Do refer to the Best Universities for Public Health by Kristen Fescoe and S. News; and the Best Universities for Healthcare Management – Top 20 Masters Program and Best Universities.
    Scoring 298+ in GRE and 6.5 in IELTS (or 90 in TOEFL) can definitely give you good chances to take up admission in good universities, if not at the Top 20. With a Masters Degree in Public Health, you can end up as Healthcare Consultant, Healthcare Policy-Maker, Nutritionist, Food Safety Inspector, Medical Officer, Health Educator, Clinical Researcher etc.
    The salary would be in the range of USD $40,000 and USD $120,000 annually after one year of experience.
  • Registered or Licensed Pharmacist (Pharmacy Jobs) Abroad: This is not that easy, but opportunities are there. Countries like Canada, US, UK, Australia do allow international pharmacy graduates to take up jobs as community pharmacists in their countries. Check out the details for CanadaUSUKAustralia

Entrepreneurship

This is the career path I would love to see Pharmacy graduates to pursue. The start-up culture in the pharmaceutical industry is extremely rare. There are lot of reasons.
The product needs to be of zero-defect and that is why lot of regulations are in place; and then there will be costly instruments and machinery.
Investment will be quite big and the concept of venture capital (VC) is still very new in India. The start-up incubating culture is also very much missing in the Colleges and/or Universities.
Few themes for entrepreneurship
  • New drug molecule / Active Pharmaceutical Ingredients (API) / New Chemical Entity (NCE)
  • Production of raw materials (excipients and other ingredients)
  • Manufacturing and Production of new formulations
  • Preparation of Biologicals
  • Sub-Contracting for Manufacturing
  • Sub-contracting for R&D – similar to CRO concept
  • E-commerce – few students should definitely try it in the Pharmaceutical/Healthcare Industry as well (very few ventures in the market so far).
If you are looking for further information and inspirations – read Challenges for Pharma Entrepreneurs and The Hidden Pharma Billionaires, and can consult FOPE.
In India, Bangalore is doing exceedingly well as the hub of Healthcare start-ups. Know about the start-up ecosystem, recent developments and top healthcare start-ups in the post Bangalore – the hub for Healthcare Startups in India by Rajesh Shenoy.
If you have got the ability to think out-of-box, courage to take risks and burning desire for value creation and innovation – then do give a shot at entrepreneurship.

Current Problems and Future Prospects

There has been a tremendous increase in the number of Pharmacy colleges in India, and hence the number of Pharmacy graduates is increasing year by year. The pharmaceutical industry is either reluctant to hire fresher or employ graduates at a very low salary scale; and the scenario is not so different for M.Pharm graduates.
The PhD degree has also become a joke in few universities (ref. Present Status of Pharmacy Profession in India).
The research and development activity in the Indian pharmaceutical industry still needs a lot of support in terms of funding. The pharmacy education in India is suffering from serious problems; and the core streams like Community Pharmacy and Hospital Pharmacy have been neglected too much (ref. Pharmacy Education in India: Strategies for a Better Future).
Recently The Hindu also reported about this issue Pharm.D graduates take to the Streets. Obviously, the pharmacy graduates are getting disheartened and frustrated.
But, it has an offer a lot if you are passionate, hardworking and strategic enough. Some key points about Pharmacy and Pharmaceutical Sciences are:
  • You learn a lot about the basics of Biology, Chemistry and little bit of Engineering – you can have lot of interesting and rewarding career options (Pharmaceuticals, Healthcare, FMCG, Finance, Marketing, Education, Agriculture, Chemicals, Govt. sector, Cosmetics etc.)
  • Even if you are not a genius and/or naturally gifted, you can have a lucrative career, provided you are tenacious enough
  • Healthcare is such a domain that it will always be on demand irrespective of economic boom, inflation or recession. So even if it is a low-earning job, you will have very less chances of being actually jobless
Source: http://www.careerizma.com/blog/pharmacy-careers-jobs/

Events